Mark Everett Schulte, M.D.

Medicare Part B Activity

Reported 30,612 Medicare fee-for-service service lines in 2024.

Activity Percentile

98.5%

Rank by Services

10 of 665

Total Services

30,612

Est. Allowed Value

$849,427.53

Dataset Year

2024

Drug Code Share

96.9%

Estimated allowed value reflects Medicare fee-for-service allowed amounts only. It does not include Medicare Advantage, commercial insurance, cash-pay services, or employment compensation.

Peers are grouped by the broader Internal Medicine classification rather than the exact subspecialty label shown elsewhere on the page.

Drug-related HCPCS codes make up 96.9% of reported Medicare services, so the claim mix is dominated by administered-drug billing lines.

Top Clinical Services

• 96413: Administration of chemotherapy into vein, 1 hour or less

  321 services | $38,752.94

• 99214: Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more

  229 services | $27,596.13

• 96415: Administration of chemotherapy into vein, each additional hour

  147 services | $3,839.03

• G2211: Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's

  122 services | $1,878.43

• 20610: Aspiration and/or injection of fluid from large joint

  48 services | $2,626.72

Common Drug-Related Codes

• J0129: Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)

  11,250 services | $479,465.89

• J1602: Injection, golimumab, 1 mg, for intravenous use

  7,650 services | $82,719.71

• J1745: Injection, infliximab, excludes biosimilar, 10 mg

  4,791 services | $150,654.48